Fexofenadine hydrochloride/Pseudoephedrine hydrochloride

盐酸非索非那定/盐酸伪麻黄碱

Report date: 2022/09/06 17:03:25

Base Information

Drug NameFexofenadine hydrochloride/Pseudoephedrine hydrochloride
Drug Alias NameAllegra-DDellegra
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsAlpha adrenergic receptor agonists
TargetsHistamine H1 receptorAlpha adrenergic receptor
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsRhinitis, Allergic
Approved Indications in ChinaRhinitis, Allergic
Original Approved Country/TerritoryHaiti
Original Approved Date1997/09/22
Country/TerritoryUnited StatesHaitiMainland China +[4] 
CombinationsYes Pseudoephedrine HydrochlorideFexofenadine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiSanofi-Aventis U.S. LlcChina National Pharmaceutical Group Corporation Guangdong Global Pharmaceutical
Inactive CompaniesN/A
Active IndicationsRhinitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeR01BA52
Related LinksKEGG